| . | Total Population (n = 951) . | Whites (n = 505) . | AAs (n = 446) . | P value . |
|---|---|---|---|---|
| Age, y | 48.8 ± 10.8 | 49.6 ± 11.3 | 47.9 ± 10.1 | .016 |
| Female, % | 522 (54.9) | 272 (53.9) | 250 (56.1) | .514 |
| History of hypertension, % | 284 (29.9) | 113 (22.4) | 171 (38.3) | <.001 |
| History of diabetes, % | 84 (8.9) | 26 (5.1) | 58 (12.7) | <.001 |
| Current smoking, % | 196 (22.0) | 70 (14.9) | 126 (29.9) | <.001 |
| Waist circumference, cm | 96.7 [86.9, 108.0] | 94.1 [84.5, 105.8] | 98.6 [88.4, 111.1] | .006 |
| BMI, kg/m2 | 27.0 [23.4, 32.1] | 25.4 [22.7, 29.0] | 29.2 [24.9, 35.0] | <.001 |
| Systolic blood pressure, mm Hg | 118.0 [108, 129] | 115 [107.0, 137.0] | 121 [111.0, 132.0] | <.001 |
| Diastolic blood pressure, mm Hg | 76.0 [69.0, 83.0] | 74.0 [67.0, 80.0] | 78.0 [70.5, 86.0] | <.001 |
| Triglycerides, mg/dL | 91.0 [65.0, 126.0] | 95.0 [66.5, 133.0] | 87.0 [63.3, 115.0] | .032 |
| LDL-C, mg/dL | 111.0 [91.0, 134.0] | 111.0 [91.5, 130.0] | 111.5 [90.0, 138] | .979 |
| HDL-C, mg/dL | 58.0 [47.0,70.0] | 57.0 [46.8,71.0] | 58.0 [48.0,69.0] | .892 |
| Glucose, mg/dL | 87.0 [82.0, 94.0] | 88.0 [82.0, 94.0] | 87.0 [81.0, 95.0] | .307 |
| Risk scores | ||||
| Framingham risk score | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | .354 |
| MetS, % (n = 951) | 228 (24.0) | 108 (21.4) | 120 (26.9) | .048 |
| Vascular function testing | ||||
| PVA | 218.1 [102, 506] | 256.5 [116, 555] | 184.7 [91, 427] | <.001 |
| RHI, AU | 2.20 [1.8–2.6] | 2.30 [1.9–2.7] | 2.06 [1.7–2.5] | <.001 |
| CAIx, % | 21.0 [11.0–29.0] | 20 [9.0–27.0] | 23.0 [13.0–31.0] | <.001 |
| PWV, m/sec | 7 [6.1–8.1] | 6.8 [6.0–7.8] | 7.3 [6.3–8.4] | <.001 |
| . | Total Population (n = 951) . | Whites (n = 505) . | AAs (n = 446) . | P value . |
|---|---|---|---|---|
| Age, y | 48.8 ± 10.8 | 49.6 ± 11.3 | 47.9 ± 10.1 | .016 |
| Female, % | 522 (54.9) | 272 (53.9) | 250 (56.1) | .514 |
| History of hypertension, % | 284 (29.9) | 113 (22.4) | 171 (38.3) | <.001 |
| History of diabetes, % | 84 (8.9) | 26 (5.1) | 58 (12.7) | <.001 |
| Current smoking, % | 196 (22.0) | 70 (14.9) | 126 (29.9) | <.001 |
| Waist circumference, cm | 96.7 [86.9, 108.0] | 94.1 [84.5, 105.8] | 98.6 [88.4, 111.1] | .006 |
| BMI, kg/m2 | 27.0 [23.4, 32.1] | 25.4 [22.7, 29.0] | 29.2 [24.9, 35.0] | <.001 |
| Systolic blood pressure, mm Hg | 118.0 [108, 129] | 115 [107.0, 137.0] | 121 [111.0, 132.0] | <.001 |
| Diastolic blood pressure, mm Hg | 76.0 [69.0, 83.0] | 74.0 [67.0, 80.0] | 78.0 [70.5, 86.0] | <.001 |
| Triglycerides, mg/dL | 91.0 [65.0, 126.0] | 95.0 [66.5, 133.0] | 87.0 [63.3, 115.0] | .032 |
| LDL-C, mg/dL | 111.0 [91.0, 134.0] | 111.0 [91.5, 130.0] | 111.5 [90.0, 138] | .979 |
| HDL-C, mg/dL | 58.0 [47.0,70.0] | 57.0 [46.8,71.0] | 58.0 [48.0,69.0] | .892 |
| Glucose, mg/dL | 87.0 [82.0, 94.0] | 88.0 [82.0, 94.0] | 87.0 [81.0, 95.0] | .307 |
| Risk scores | ||||
| Framingham risk score | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | .354 |
| MetS, % (n = 951) | 228 (24.0) | 108 (21.4) | 120 (26.9) | .048 |
| Vascular function testing | ||||
| PVA | 218.1 [102, 506] | 256.5 [116, 555] | 184.7 [91, 427] | <.001 |
| RHI, AU | 2.20 [1.8–2.6] | 2.30 [1.9–2.7] | 2.06 [1.7–2.5] | <.001 |
| CAIx, % | 21.0 [11.0–29.0] | 20 [9.0–27.0] | 23.0 [13.0–31.0] | <.001 |
| PWV, m/sec | 7 [6.1–8.1] | 6.8 [6.0–7.8] | 7.3 [6.3–8.4] | <.001 |
Abbreviation: LDL-C, low-density lipoprotein cholesterol. Values shown are mean ± SDs or number (percentage) for normally distributed variables or median [interquartile range] for nonnormally distributed variables. Bold values indicate statistically significant difference (P < .05).
| . | Total Population (n = 951) . | Whites (n = 505) . | AAs (n = 446) . | P value . |
|---|---|---|---|---|
| Age, y | 48.8 ± 10.8 | 49.6 ± 11.3 | 47.9 ± 10.1 | .016 |
| Female, % | 522 (54.9) | 272 (53.9) | 250 (56.1) | .514 |
| History of hypertension, % | 284 (29.9) | 113 (22.4) | 171 (38.3) | <.001 |
| History of diabetes, % | 84 (8.9) | 26 (5.1) | 58 (12.7) | <.001 |
| Current smoking, % | 196 (22.0) | 70 (14.9) | 126 (29.9) | <.001 |
| Waist circumference, cm | 96.7 [86.9, 108.0] | 94.1 [84.5, 105.8] | 98.6 [88.4, 111.1] | .006 |
| BMI, kg/m2 | 27.0 [23.4, 32.1] | 25.4 [22.7, 29.0] | 29.2 [24.9, 35.0] | <.001 |
| Systolic blood pressure, mm Hg | 118.0 [108, 129] | 115 [107.0, 137.0] | 121 [111.0, 132.0] | <.001 |
| Diastolic blood pressure, mm Hg | 76.0 [69.0, 83.0] | 74.0 [67.0, 80.0] | 78.0 [70.5, 86.0] | <.001 |
| Triglycerides, mg/dL | 91.0 [65.0, 126.0] | 95.0 [66.5, 133.0] | 87.0 [63.3, 115.0] | .032 |
| LDL-C, mg/dL | 111.0 [91.0, 134.0] | 111.0 [91.5, 130.0] | 111.5 [90.0, 138] | .979 |
| HDL-C, mg/dL | 58.0 [47.0,70.0] | 57.0 [46.8,71.0] | 58.0 [48.0,69.0] | .892 |
| Glucose, mg/dL | 87.0 [82.0, 94.0] | 88.0 [82.0, 94.0] | 87.0 [81.0, 95.0] | .307 |
| Risk scores | ||||
| Framingham risk score | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | .354 |
| MetS, % (n = 951) | 228 (24.0) | 108 (21.4) | 120 (26.9) | .048 |
| Vascular function testing | ||||
| PVA | 218.1 [102, 506] | 256.5 [116, 555] | 184.7 [91, 427] | <.001 |
| RHI, AU | 2.20 [1.8–2.6] | 2.30 [1.9–2.7] | 2.06 [1.7–2.5] | <.001 |
| CAIx, % | 21.0 [11.0–29.0] | 20 [9.0–27.0] | 23.0 [13.0–31.0] | <.001 |
| PWV, m/sec | 7 [6.1–8.1] | 6.8 [6.0–7.8] | 7.3 [6.3–8.4] | <.001 |
| . | Total Population (n = 951) . | Whites (n = 505) . | AAs (n = 446) . | P value . |
|---|---|---|---|---|
| Age, y | 48.8 ± 10.8 | 49.6 ± 11.3 | 47.9 ± 10.1 | .016 |
| Female, % | 522 (54.9) | 272 (53.9) | 250 (56.1) | .514 |
| History of hypertension, % | 284 (29.9) | 113 (22.4) | 171 (38.3) | <.001 |
| History of diabetes, % | 84 (8.9) | 26 (5.1) | 58 (12.7) | <.001 |
| Current smoking, % | 196 (22.0) | 70 (14.9) | 126 (29.9) | <.001 |
| Waist circumference, cm | 96.7 [86.9, 108.0] | 94.1 [84.5, 105.8] | 98.6 [88.4, 111.1] | .006 |
| BMI, kg/m2 | 27.0 [23.4, 32.1] | 25.4 [22.7, 29.0] | 29.2 [24.9, 35.0] | <.001 |
| Systolic blood pressure, mm Hg | 118.0 [108, 129] | 115 [107.0, 137.0] | 121 [111.0, 132.0] | <.001 |
| Diastolic blood pressure, mm Hg | 76.0 [69.0, 83.0] | 74.0 [67.0, 80.0] | 78.0 [70.5, 86.0] | <.001 |
| Triglycerides, mg/dL | 91.0 [65.0, 126.0] | 95.0 [66.5, 133.0] | 87.0 [63.3, 115.0] | .032 |
| LDL-C, mg/dL | 111.0 [91.0, 134.0] | 111.0 [91.5, 130.0] | 111.5 [90.0, 138] | .979 |
| HDL-C, mg/dL | 58.0 [47.0,70.0] | 57.0 [46.8,71.0] | 58.0 [48.0,69.0] | .892 |
| Glucose, mg/dL | 87.0 [82.0, 94.0] | 88.0 [82.0, 94.0] | 87.0 [81.0, 95.0] | .307 |
| Risk scores | ||||
| Framingham risk score | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | 4.0 [2.0, 7.0] | .354 |
| MetS, % (n = 951) | 228 (24.0) | 108 (21.4) | 120 (26.9) | .048 |
| Vascular function testing | ||||
| PVA | 218.1 [102, 506] | 256.5 [116, 555] | 184.7 [91, 427] | <.001 |
| RHI, AU | 2.20 [1.8–2.6] | 2.30 [1.9–2.7] | 2.06 [1.7–2.5] | <.001 |
| CAIx, % | 21.0 [11.0–29.0] | 20 [9.0–27.0] | 23.0 [13.0–31.0] | <.001 |
| PWV, m/sec | 7 [6.1–8.1] | 6.8 [6.0–7.8] | 7.3 [6.3–8.4] | <.001 |
Abbreviation: LDL-C, low-density lipoprotein cholesterol. Values shown are mean ± SDs or number (percentage) for normally distributed variables or median [interquartile range] for nonnormally distributed variables. Bold values indicate statistically significant difference (P < .05).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
